CytRx puts idle assets to use

CytRx puts idle assets to use

In a move to manage its risk profile, CytRx Corp. (CYTR) established Proceutics Inc., a preclinical research organization that will use CYTR's preclinical facilities to generate revenues.

Read the full 331 word article

How to gain access

Continue reading with a
two-week free trial.